SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000935836-16-000726
Filing Date
2016-02-12
Accepted
2016-02-11 19:33:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 aegerion13ga1.htm SC 13G/A 48519
  Complete submission text file 0000935836-16-000726.txt   50176
Mailing Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142
Business Address ONE MAIN STREET SUITE 800 CAMBRIDGE MA 02142 (617) 500-7867
Aegerion Pharmaceuticals, Inc. (Subject) CIK: 0001338042 (see all company filings)

IRS No.: 202960116 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-85739 | Film No.: 161413648
SIC: 2834 Pharmaceutical Preparations

Mailing Address P.O. BOX 250 BEND OR 97709
Business Address P.O. BOX 250 BEND OR 97709 541-647-5664
STONEPINE CAPITAL, L.P. (Filed by) CIK: 0001370042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A